A fourth Covid-19 booster dose may be needed to prevent a return to ‘pandemic phase’
Future waves of increased Covid-19 transmission in the US are still possible and may require another round of vaccinations.
By
Covid-19
Latest in
Covid-19
Overcoming vaccine scepticism in Africa will reduce malaria burden
Malaria is a vector-borne disease caused by parasites of the genus Plasmodium. Malaria is transmitted through the bite of the…
By
Covid-19 diagnoses may drive increase in heart failure cases
As the Covid-19 pandemic stretches into its third year, the long-term effects of acute infection are beginning to become more…
By
Pfizer, BioNTech’s Covid-19 booster offers immune response in children
Subanalysis findings showed that the booster offered a 36-fold rise in SARS-CoV-2 Omicron neutralising titers.
SyneuRx completes enrolment in Phase II trial of Covid-19 oral antiviral
The trial will enable the selection of the optimal dose for the Phase III trial study, anticipated to commence soon.
FDA grants approval for BioCardia’s Covid-19 stem cell therapy trial
The initial portion of the trial will assess increasing doses of the NK1R+ MSCs in adult patients.
Veru’s Covid-19 drug cuts mortality by 55% in Phase III trial
Due to efficacy, the Independent Data Safety Monitoring Committee advised halting the trial of sabizabulin early.
Akston doses first volunteers in Phase II/III Covid-19 vaccine trial
Assessing the safety, tolerability and humoral immunogenicity profile of the vaccine at day 56 is the study’s primary objective.